⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.

Popular Peptides

TRZ (10 Vials)

Third-Party Tested
Quantity
Price
$295.00
Select Size
Quick Quantity Selection

In stock – Ships same day

SSL Secured Secure Checkout Guaranteed Delivery Third-Party Tested

Compound Information

Technical specifications

Molecular Profile

What Is TRZ (10 Vials)?

Type Dual GIP and GLP-1 Receptor Agonist
CAS Number 2023788-19-2
Molecular Weight 4813.5 g/mol
Molecular Weight (Cu) N/A
Amino Acids 39 Amino Acids
Sequence Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(C20-fatty-diacid)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Formula $C_{225}H_{348}N_{48}O_{68}$
Storage Requirements

Stability Information

Lyophilized powder; keep sealed, dry, and protected from light.Store at a stable temperature and minimize warming/cooling cycles.After reconstitution, avoid repeated freeze–thaw cycles.
Lyophilized storage
Lyophilized Powder -20°C
Reconstituted storage
Reconstituted 2-8°C

About TRZ (10 Vials)

TRZ is a synthetic peptide researched for its unique ability to act as a dual agonist for the Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. Supplied in a 10-vial pack as a stable lyophilized powder, it is a primary subject of study in fat metabolism and weight management research. This compound provides a consistent reagent for investigating how the activation of multiple incretin pathways can synergistically influence insulin sensitivity and metabolic signaling. It is intended strictly for laboratory research and development purposes by qualified professionals only.

Mechanism of Action

The mechanism involves the simultaneous activation of both GIP and GLP-1 receptors. GLP-1 receptor activation is studied for its ability to slow gastric emptying and suppress appetite signaling in the brain. GIP receptor activation is researched for its role in improving insulin sensitivity and regulating lipid metabolism in adipose tissue. In research assays, this dual-action “twincretin” approach is investigated for its potential to optimize metabolic homeostasis more effectively than single-receptor agonists.

What Research Has Shown

Metabolic Research
99 Purity Percentage (HPLC Verified)
Dual Incretin Signaling Efficiency
TRZ Dual Agonist 95.5%
Trial details: Investigative studies focusing on the synergistic effects of GIP and GLP-1 receptor activation on glucose-dependent insulin secretion and energy homeostasis in experimental models.
Bioenergetic Results

Multi-Pathway Metabolic Homeostasis

Findings from GIP and GLP-1 receptor studies

97% Insulin Sensitivity Enhanced Glucose Metabolism
Note: Results highlight the compound's ability to act as a potent dual-system metabolic regulator.

Research Highlights

Product Specifications

Research Studies

Frequently Asked Questions

What is a dual agonist in the context of TRZ?

It means the compound targets two different receptors simultaneously: the Glucose-dependent Insulinotropic Polypeptide (GIP) and the Glucagon-Like Peptide-1 (GLP-1) receptors.

Is this product FDA evaluated?

No, these products are intended strictly for laboratory research and have not been evaluated or approved by the FDA for human use.

Molecule illustration

Related Products

VIP

Hormone Analogs

From

Price range: $40.00 through $45.00

Select options This product has multiple variants. The options may be chosen on the product page

Lemon Bottle

Hormone Analogs

From

$45.00

TB-500

Cyclic Peptides

From

Price range: $35.00 through $64.00

Select options This product has multiple variants. The options may be chosen on the product page

Ipamorelin

Hormone Analogs

From

Price range: $28.00 through $42.00

Select options This product has multiple variants. The options may be chosen on the product page